scispace - formally typeset
D

Daniela Trisciuoglio

Researcher at National Research Council

Publications -  89
Citations -  9685

Daniela Trisciuoglio is an academic researcher from National Research Council. The author has contributed to research in topics: Cancer & Apoptosis. The author has an hindex of 35, co-authored 77 publications receiving 8296 citations. Previous affiliations of Daniela Trisciuoglio include Sapienza University of Rome & Science Applications International Corporation.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

TL;DR: The role of the fundamental regulators of apoptosis are highlighted and how their deregulation, including activation of anti-apoptotic factors or inactivation of pro-ap optotic factors ends up in cancer cell resistance to therapies.
Journal ArticleDOI

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

TL;DR: Results suggest that antiangiogenic effects may substantially contribute to the antitumor activity observed with temsirolimus in breast cancer.
Journal ArticleDOI

The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis

TL;DR: The identification of ID4 as a transcriptional target of gain-of-function p53 mutants R175H, R273H and R280K highlights the transcriptional axis mutant p53, E2F1 and ID 4 as a still undefined molecular mechanism contributing to tumor neo-angiogenesis.
Journal ArticleDOI

Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation

TL;DR: A novel role is established in determining protection of ovarian carcinoma cells against paclitaxel-induced apoptosis through Bcl-2-dependent and PI3-K-mediated Akt pathways and suggest that ET-1 and ET(A)R could represent important targets for anticancer therapy.